Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?
about
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaColistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patientsSusceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of TurkeyCritical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infectionsMechanisms of Antimicrobial Resistance in ESKAPE PathogensBloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteriaResistance to antibiotics targeted to the bacterial cell wallCeftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combinationOvercoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual frameworkColistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapyThe AEROPATH project targetingPseudomonas aeruginosa: crystallographic studies for assessment of potential targets in early-stage drug discoveryAssessment of Pseudomonas aeruginosa N5,N10-Methylenetetrahydrofolate Dehydrogenase - Cyclohydrolase as a Potential Antibacterial Drug TargetMortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studiesCarbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the PuzzleCosts of antibiotic resistance - separating trait effects and selective effectsEvaluation of multidrug efflux pump inhibitors by a new method using microfluidic channelsCharacterization of a novel Zn²⁺-dependent intrinsic imipenemase from Pseudomonas aeruginosaSurveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based studyThe periplasmic protein TolB as a potential drug target in Pseudomonas aeruginosaA locked nucleic acid (LNA)-based real-time PCR assay for the rapid detection of multiple bacterial antibiotic resistance genes directly from positive blood cultureA Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosaPolyamino-Isoprenic Derivatives Block Intrinsic Resistance of P. aeruginosa to Doxycycline and Chloramphenicol In VitroCarbapenem-Resistant Bacteria Recovered from Faeces of Dairy Cattle in the High Plains Region of the USAA potent synthetic inorganic antibiotic with activity against drug-resistant pathogensGreen synthesis of silver nanoparticles in aloe vera plant extract prepared by a hydrothermal method and their synergistic antibacterial activityGenomics of antibiotic-resistance prediction in Pseudomonas aeruginosa.Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units.In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosaAlternative substrates selective for S-adenosylmethionine synthetases from pathogenic bacteriaActivity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strainsMolecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms.β-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket.Surveillance of antimicrobial resistance among clinical isolates recovered from a tertiary care hospital in Al Qassim, Saudi Arabia.Efflux pump regulatory genes mutations in multidrug resistance Pseudomonas aeruginosa isolated from wound infections in Isfahan hospitals.Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.nBioChip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream Applications.Evaluation of the short-term effects of antimicrobial stewardship in the intensive care unit at a tertiary hospital in China.Activation of multiple transcriptional regulators by growth restriction in Pseudomonas aeruginosa.
P2860
Q22241905-502FF41C-1B48-41DB-8090-25AC5FA41985Q24673399-9DDE69DA-59C7-40C6-9272-CCAB2444B90CQ24798988-E4605FED-16DC-4433-B087-A91B6CBF95BAQ26747429-C22E3366-C8A7-418B-A8EA-AF3B5A9D837CQ26747594-45152B19-B95B-468D-AF82-4763F3373B02Q26795565-6BF37A08-EB56-4DF7-AD03-113ECCAA6EF5Q26859841-8A5747B8-1EEB-46AE-8BCD-580846DAE63EQ26998883-331BC4D0-DBB2-4721-9181-D1983621F140Q27000458-95AB82E5-5FC9-47C2-A20F-E10C44A8B246Q27014993-6563B02C-65B6-4639-A411-8E72C4E922CAQ27675787-47C44847-FF98-4701-BF10-87F5D8E956A5Q27678891-A4BBC8BF-302C-458B-B68A-589443503C56Q28068844-7BEC394B-607B-4031-8683-8C7DEB3D5249Q28078925-429E7E93-3A00-4A02-806D-FBCDD6FCF867Q28082095-366652D3-42B5-47F6-A183-D2B451089D0FQ28477724-348BEF78-A38A-4486-B0FF-9DC48E1B3911Q28492716-85F64D0B-A238-45B3-A694-8C880C2DFD1FQ28535024-F7F6E9D0-C378-4C74-BFEE-C275E7093F77Q28541613-4038DC69-EF55-425A-956B-D1903745B28BQ28544064-3D86C565-EB76-499C-8161-EF71AAEE845CQ28550146-057A33B4-6510-473B-BD94-59EC31DCEA42Q28551861-C7B523D7-1C5E-497D-B652-26B182634450Q28552964-0F4EDF2A-BE5C-4AA6-B12D-469933FDA0E3Q28817444-A7AB0635-8E6A-4C9B-9E83-6638CAB59446Q28821293-F6CC9C8E-273D-4269-9CE7-6149818B1148Q30234118-3EC944FA-748D-4521-89A4-0871C8959182Q31071398-EB174B5B-DCFC-4B3E-9E7D-D95AD236DA78Q33209355-1D8AD4B2-E9C4-4D9F-B6C2-AC9F80F5B96DQ33319504-5F978F54-CA55-4462-BB92-64E90232FC57Q33491829-B68BB878-37BA-4908-AAA4-0D0D194F8046Q33555516-43F26DD3-D425-49AC-8EA2-905B5A03F508Q33613660-778F2E08-4F8C-4A1A-8ADB-AA6999F4E446Q33648133-74E8FFF8-0EA2-4D37-935B-90BA2E8762AAQ33675820-BE337C7A-7CC0-473C-A84E-30889A71B700Q33690429-1DDEA470-B9C8-4E39-941B-80C7AFF27591Q33776291-90131206-4F16-414F-9836-5E9A324CF466Q33836550-19ACD7D7-1A8F-41EA-B151-6DC301EF0071Q33849725-4999B66A-8937-497D-BFFE-A8E5DBE704D3Q33855601-04E7053B-72AE-4FDE-998C-E849284488B1Q33861712-C1A15342-E66F-41D6-814F-8E7D87EEA8CB
P2860
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Multiple mechanisms of antimic ...... ruginosa: our worst nightmare?
@en
Multiple mechanisms of antimic ...... ruginosa: our worst nightmare?
@nl
type
label
Multiple mechanisms of antimic ...... ruginosa: our worst nightmare?
@en
Multiple mechanisms of antimic ...... ruginosa: our worst nightmare?
@nl
prefLabel
Multiple mechanisms of antimic ...... ruginosa: our worst nightmare?
@en
Multiple mechanisms of antimic ...... ruginosa: our worst nightmare?
@nl
P2860
P356
P1476
Multiple mechanisms of antimic ...... ruginosa: our worst nightmare?
@en
P2093
David M Livermore
P2860
P304
P356
10.1086/338782
P407
P577
2002-01-25T00:00:00Z